Eton Pharmaceuticals, Inc. (ETON) financial statements (2021 and earlier)

Company profile

Business Address 21925 W. FIELD PARKWAY
DEER PARK, IL 60010-7208
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments211227
Cash and cash equivalents211227
Receivables00 
Inventory, net of allowances, customer advances and progress billings10 
Inventory10 
Prepaid expense  1
Other undisclosed current assets22 
Total current assets:251528
Noncurrent Assets
Operating lease, right-of-use asset00
Property, plant and equipment111
Intangible assets, net (including goodwill)11 
Intangible assets, net (excluding goodwill)11 
Other noncurrent assets000
Total noncurrent assets:221
TOTAL ASSETS:261728
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities422
Accounts payable211
Accrued liabilities111
Other undisclosed current liabilities0  
Total current liabilities:422
Noncurrent Liabilities
Long-term debt and lease obligation00 
Operating lease, liability00
Other undisclosed noncurrent liabilities75 
Total noncurrent liabilities:75 
Total liabilities:1172
Stockholders' equity
Stockholders' equity attributable to parent161126
Common stock000
Additional paid in capital1087572
Accumulated deficit(92)(64)(46)
Total stockholders' equity:161126
TOTAL LIABILITIES AND EQUITY:261728

Income statement (P&L) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
Revenues01 
Cost of revenue
(Cost of Goods and Services Sold)
(0)(0) 
Gross profit:(0)1 
Operating expenses(27)(19)(10)
Operating loss:(27)(19)(10)
Nonoperating expense(1)  
Interest and debt expense(1)  
Loss from continuing operations before equity method investments, income taxes:(29)(19)(10)
Other undisclosed income (loss) from continuing operations before income taxes10(2)
Loss from continuing operations before income taxes:(28)(18)(13)
Income tax expense  (3)
Loss before gain (loss) on sale of properties:(28)(18)(15)
Other undisclosed net income  3
Net loss attributable to parent:(28)(18)(13)
Other undisclosed net loss available to common stockholders, basic  (24)
Net loss available to common stockholders, diluted:(28)(18)(37)

Comprehensive Income ($ in millions)

12/31/2020
12/31/2019
12/31/2018
Net loss:(28)(18)(13)
Comprehensive loss, net of tax, attributable to parent:(28)(18)(13)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: